Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2010 Jan;53(1):204-5.
doi: 10.1007/s00125-009-1572-8. Epub 2009 Oct 27.

Diabetes treatment with insulin glargine and risk of malignancy: methodological pitfalls and ethical issues

D Simon
Comment

Diabetes treatment with insulin glargine and risk of malignancy: methodological pitfalls and ethical issues

D Simon. Diabetologia. 2010 Jan.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Hemkens LG, Grouven U, Bender R, et al. Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. Diabetologia. 2009;52:1732–1744. doi: 10.1007/s00125-009-1418-4. - DOI - PMC - PubMed
    1. Yki-Järvinen H, Kauppinen-Mäkelin R, Tikkainen M, et al. Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study. Diabetologia. 2006;49:442–451. doi: 10.1007/s00125-005-0132-0. - DOI - PubMed
    1. Pan CY, Sinnassamy P, Chung KD, Kim KW, on behalf of the LEAD Study Investigators Group Insulin glargine versus NPH insulin therapy in Asian type 2 diabetes patients. Diabetes Res Clin Pract. 2007;76:111–118. doi: 10.1016/j.diabres.2006.08.012. - DOI - PubMed
    1. Riddle MC, Rosenstock J, Gerich J, on behalf of the Insuline Glargine 4002 Study Investigators (2003) The Treat-to-Target Trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 26:3080–3086 - PubMed
    1. Colhoun HM, SDRN Epidemiology Group (2009) Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia 52:1755–1765 Erratum 52:2469 - PMC - PubMed